Agah Ramtin 4
4 · RenovoRx, Inc. · Filed Jan 23, 2024
Insider Transaction Report
Form 4
RenovoRx, Inc.RNXT
Agah Ramtin
DirectorChief Medical Officer
Transactions
- Award
Stock Option
2024-01-19+125,132→ 125,132 totalExercise: $1.08→ Common Stock (125,132 underlying) - Award
Stock Option
2024-01-19+28,424→ 28,424 totalExercise: $1.08→ Common Stock (28,424 underlying)
Footnotes (2)
- [F1]On January 19, 2024, the Reporting Person was awarded a stock bonus of 28,424 shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan (the "Plan"). These shares were fully vested upon issuance to the Reporting Person, and expire on January 19, 2034.
- [F2]On January 19, 2024, the Reporting Person received a nonqualified stock option grant for 125,132 shares of common stock vesting over four years at a rate of 1/48 per month with no cliff, beginning vesting on February 1, 2024. The option will become fully vested and exercisable on February 1, 2028, and expires on January 19, 2034.